Building Blocks; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
Ethyl 4-?(6-?Acetyl-?3-?hydroxy-?2-?propylphenoxy)?butyrate is an intermediate in the synthesis of Tipelukast-d6 (T444872), the labeled analogue of Tipelukast, a novel oral anti-inflammatory agent, suppresses bladder hyperactivity in a rat model.